An update on the development of novel antifungal agents for eumycetoma

David J. Chandler*, Alexandro Bonifaz, Wendy W.J. van de Sande

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

1 Citation (Scopus)
27 Downloads (Pure)


Eumycetoma, a chronic subcutaneous mycosis, responds poorly to the available antifungal treatments and patients often require extensive surgical resection or amputation of the affected limb. More effective treatments are needed for eumycetoma. This article will describe some of the approaches being used to develop and evaluate new treatments for eumycetoma, summarise the latest developments and discuss the challenges that lie ahead.

Original languageEnglish
Article number1165273
JournalFrontiers in Pharmacology
Publication statusPublished - 18 May 2023

Bibliographical note

Publisher Copyright:
Copyright © 2023 Chandler, Bonifaz and van de Sande.


Dive into the research topics of 'An update on the development of novel antifungal agents for eumycetoma'. Together they form a unique fingerprint.

Cite this